Abbott Ireland Diagnostics Division · Class II · Cleared Nov 23, 2021
| K-number | K203248 |
| Device name | Albumin BCG2 |
| Applicant | Abbott Ireland Diagnostics Division |
| Product code | CIX |
| Device class | Class II |
| Decision date | Nov 23, 2021 |
| Decision | Substantially Equivalent |
| Regulation | 862.1035 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov